Mirum Pharmaceuticals Inc.
MIRM | NASDAQ
$91.64
-$0.36 (-0.39%)
Sep 22, 2026, 10:58 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -857.38M | -790.16M | -5.73M | 2.91M | -5.86M | -14.68M | -23.79M | -14.24M | -24.64M | -25.28M | -35.66M | -23.59M | -74.04M | -30.13M | -36.43M | -35.71M | -26.92M | -36.61M | 57.55M | -47.11M | -43.89M | -50.53M |
Depreciation & Amortization | 13.81M | 6.87M | 6.07M | 6.06M | 6.06M | 6.05M | 6.06M | 6.06M | 5.85M | 5.66M | 5.49M | 2.66M | 1.34M | 1.34M | 1.33M | 1.1M | 705K | 443K | 437K | 178K | 175K | 185K |
Stock-Based Compensation | 66.78M | 36.2M | 19.03M | 18.13M | 18.47M | 15.8M | 13.25M | 11.91M | 11.84M | 11.45M | 9.72M | 8.39M | 8.36M | 8.56M | 6.9M | 6.73M | 6.82M | 6.56M | 5.56M | 7.42M | 4.82M | 5.29M |
Other Working Capital | 51.97M | 59.78M | 3.84M | -7.9M | -5.73M | -3.53M | 57K | -4.98M | 1.14M | 660K | -1.07M | -2.98M | -1.02M | 26K | -1.89M | -3.5M | 1.93M | -1.05M | -2.57M | -2.72M | 49K | -429K |
Other Non-Cash Items | 441.78M | 416.1M | 704K | 442K | -67K | 2.16M | 1.1M | 1.49M | 1.58M | -565K | 14.69M | -37K | 50.51M | 4.09M | 2.89M | 3.67M | 2.29M | 3.73M | -104.23M | 4.25M | 6.02M | 3.38M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.58M | n/a | 1.09M | n/a | n/a | -328K |
Change in Working Capital | 62M | 102.22M | -14.01M | 12.15M | -6.56M | -11.3M | -1.68M | -1.23M | 1.56M | 23.94M | -10.87M | -5.64M | -3.5M | -2.63M | -8.96M | -1.82M | 3.52M | -13.8M | 6.45M | 1.06M | -7.32M | 16.8M |
Operating Cash Flow | -273.02M | -228.76M | 6.07M | 39.68M | 12.04M | -1.96M | -5.07M | 3.98M | -3.8M | 15.21M | -16.62M | -18.22M | -17.33M | -18.77M | -34.27M | -26.03M | -20.17M | -39.67M | -33.15M | -34.2M | -40.2M | -25.21M |
Capital Expenditures | -687K | -664K | -600K | -187K | -126K | -41K | -20K | -10.18M | -10.78M | -13K | -5M | n/a | -68K | -15.04M | -242K | -19K | -17K | n/a | -19M | -18K | n/a | -3K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -23.99M | n/a | -19M | n/a | n/a | -2M |
Purchase of Investments | -195.61M | -34.8M | -11.5M | -20.86M | -31.54M | -33.53M | -11.48M | -15.61M | -61.94M | n/a | n/a | n/a | -4.89M | -22.44M | n/a | -117.51M | -14.81M | n/a | -18.97M | -49.72M | -45.96M | -83.38M |
Sales Maturities Of Investments | 59.74M | 33.89M | 13.11M | 18.82M | 25.06M | 17.43M | 12.14M | 7.75M | n/a | n/a | 3M | 30M | 55.5M | 64.5M | 27M | 38M | 38.8M | 36.5M | 38M | 47.5M | 21.5M | 50.6M |
Other Investing Acitivies | -35M | n/a | n/a | n/a | n/a | n/a | n/a | -10M | -10M | n/a | n/a | -212.76M | n/a | -15M | n/a | n/a | 23.99M | n/a | 127M | n/a | n/a | 2M |
Investing Cash Flow | -171.56M | -11.57M | 1.01M | -2.23M | -6.6M | -16.13M | 641K | -18.04M | -72.72M | -13K | -2M | -182.76M | 50.55M | 27.02M | 26.76M | -79.53M | 23.97M | 36.5M | 108.02M | -2.24M | -24.46M | -32.78M |
Debt Repayment | 198.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 112.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 64.57M | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.94M | 4.77M | n/a | -1.49M | -49K | -292K | 1.34M | 720K | -120K | n/a | n/a | -320K |
Financial Cash Flow | 481.52M | 270.08M | 9M | 16.1M | 8.69M | 6.36M | 5.34M | 3.86M | 7.29M | 1.21M | 1.78M | 207.13M | 114.71M | 12.99M | -329K | 86.07M | 5.25M | 18.1M | 615K | 345K | 65.91M | 6.59M |
Net Cash Flow | 34.3M | 28.22M | 15.66M | 53.9M | 16.36M | -10.68M | -466K | -10.1M | -69.35M | 16.52M | -16.73M | 5.83M | 147.81M | 21.42M | -7.76M | -19.51M | 9M | 14.93M | 75.5M | -36.09M | 1.26M | -51.41M |
Free Cash Flow | -273.7M | -229.43M | 5.47M | 39.49M | 11.91M | -2M | -5.09M | -6.2M | -14.58M | 15.2M | -21.62M | -18.22M | -17.4M | -33.82M | -34.51M | -26.04M | -20.19M | -39.67M | -52.15M | -34.22M | -40.2M | -25.21M |
Adj. Free Cash Flow | -340.48M | -265.63M | -13.56M | 21.37M | -6.55M | -17.81M | -18.34M | -18.11M | -26.42M | 3.75M | -31.34M | -26.61M | -25.76M | -42.38M | -41.41M | -32.78M | -27.01M | -46.23M | -57.71M | -41.64M | -45.02M | -30.5M |
Maintenance CapEx | -687K | -664K | n/a | n/a | n/a | n/a | n/a | -8.55M | -9.24M | n/a | -2.96M | n/a | n/a | -14.12M | n/a | n/a | n/a | n/a | -17.44M | n/a | n/a | -3K |
Growth CapEx | n/a | n/a | -600K | -187K | -126K | -41K | -20K | -1.63M | -1.54M | -13K | -2.04M | n/a | -68K | -917.53K | -242K | -19K | -17K | n/a | -1.56M | -18K | n/a | n/a |
Owner Earnings | -273.7M | -229.43M | 6.07M | 39.68M | 12.04M | -1.96M | -5.07M | -4.57M | -13.04M | 15.21M | -19.58M | -18.22M | -17.33M | -32.9M | -34.27M | -26.03M | -20.17M | -39.67M | -50.59M | -34.2M | -40.2M | -25.21M |
Add to Watchlist
Select watchlists to add or remove MIRM